ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 37 filers reported holding ELEVATION ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,009,145 | -42.9% | 3,032,214 | +30.9% | 0.00% | -50.0% |
Q2 2023 | $3,520,968 | +11636.6% | 2,316,426 | +10637.6% | 0.00% | – |
Q2 2022 | $30,000 | -52.4% | 21,573 | +106.2% | 0.00% | – |
Q4 2021 | $63,000 | -96.2% | 10,463 | -91.5% | 0.00% | -100.0% |
Q2 2021 | $1,670,000 | – | 123,062 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Qiming U.S. Ventures Management, LLC | 2,370,142 | $3,602,616 | 3.79% |
Aisling Capital Management LP | 2,834,910 | $4,309,063 | 2.11% |
venBio Partners LLC | 2,914,255 | $4,429,668 | 1.60% |
TANG CAPITAL MANAGEMENT LLC | 4,000,000 | $6,080,000 | 0.90% |
Velan Capital Investment Management LP | 497,299 | $755,894 | 0.70% |
Ikarian Capital, LLC | 1,149,490 | $1,747,225 | 0.28% |
Samsara BioCapital, LLC | 830,565 | $1,262,459 | 0.22% |
SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $1,368,000 | 0.21% |
DAFNA Capital Management LLC | 450,000 | $684,000 | 0.19% |
BVF INC/IL | 2,312,200 | $3,514,544 | 0.10% |